Tango Therapeutics (TNGX) is down -14.9%, or -$3.71 to $21.16.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TNGX:
- Tango Therapeutics price target raised to $30 from $20 at Mizuho
- Tango Therapeutics downgraded to Neutral from Overweight at Piper Sandler
- Piper Sandler cuts Tango Therapeutics Neutral following Q1 report
- Tango Therapeutics price target raised to $55 from $28 at Leerink
- Tango Therapeutics price target raised to $33 from $19 at Wedbush